EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 28 filers reported holding EFFECTOR THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $15,185 | -98.0% | 52,343 | 0.0% | 0.00% | -100.0% |
| Q1 2024 | $753,216 | +23.1% | 52,343 | -96.0% | 0.00% | 0.0% |
| Q4 2023 | $611,634 | -22.1% | 1,308,587 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $785,021 | -27.7% | 1,308,587 | 0.0% | 0.00% | -40.0% |
| Q2 2023 | $1,086,389 | +135.4% | 1,308,587 | 0.0% | 0.01% | +150.0% |
| Q1 2023 | $461,539 | -17.5% | 1,308,587 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $559,552 | +74606.5% | 1,308,587 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $749 | -100.0% | 1,308,587 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $1,858,000 | -64.6% | 1,308,587 | 0.0% | 0.01% | -53.8% |
| Q1 2022 | $5,248,000 | -32.7% | 1,308,587 | 0.0% | 0.01% | -35.0% |
| Q4 2021 | $7,799,000 | -57.6% | 1,308,587 | 0.0% | 0.02% | -51.2% |
| Q3 2021 | $18,386,000 | – | 1,308,587 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,822,114 | $27,357,000 | 14.00% |
| Abingworth LLP | 4,822,114 | $18,903,000 | 5.36% |
| Column Group LLC | 4,309,329 | $17,280,000 | 3.20% |
| OUP Management Co., LLC | 1,025,697 | $4,113,000 | 3.13% |
| SECTORAL ASSET MANAGEMENT INC | 2,382,744 | $9,555,000 | 1.70% |
| Parallel Advisors, LLC | 677,452 | $2,744,000 | 0.11% |
| Oasis Management Co Ltd. | 100,000 | $401,000 | 0.06% |
| Blackstone Inc. | 1,308,587 | $5,248,000 | 0.01% |
| ALPS ADVISORS INC | 46,537 | $187,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 548 | $2,000 | 0.00% |